Podcasts about health care senior analyst

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, joins Scott Becker to discuss how tariffs and economic uncertainty are reshaping the deal-making landscape.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, joins Scott Becker to discuss how tariffs and economic uncertainty are reshaping the deal-making landscape.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares key insights from recent research on the increasing complexity of business operations, the impact on private equity and middle-market companies, and strategies leaders can use to navigate today's challenging deal environment.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares key insights from recent research on the increasing complexity of business operations, the impact on private equity and middle-market companies, and strategies leaders can use to navigate today's challenging deal environment.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, provides a nuanced analysis of the DeepSeek AI model and the broader cost reduction trends in AI development.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, provides a nuanced analysis of the DeepSeek AI model and the broader cost reduction trends in AI development.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his insights on the shifting interest rate environment and its implications for capital markets in 2025.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his insights on the shifting interest rate environment and its implications for capital markets in 2025.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his outlook for the 2025 deal market, highlighting key trends, challenges, and opportunities in the middle market.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his outlook for the 2025 deal market, highlighting key trends, challenges, and opportunities in the middle market.

In this episode, Scott Becker is joined by Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Matt shares insights on the potential for a robust IPO market in 2025, the shift toward mature, profitable companies going public, and how private equity funds are adapting with creative liquidity solutions.

In this episode, Scott Becker is joined by Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Matt shares insights on the potential for a robust IPO market in 2025, the shift toward mature, profitable companies going public, and how private equity funds are adapting with creative liquidity solutions.

In this episode, Scott Becker is joined by Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, to discuss RSM's 2025 economic forecast. They delve into projections for GDP growth, employment trends, the private equity landscape, and the potential impact of regulatory changes under the incoming administration. Matt also […]

In this episode, Scott Becker is joined by Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, to discuss RSM's 2025 economic forecast. They delve into projections for GDP growth, employment trends, the private equity landscape, and the potential impact of regulatory changes under the incoming administration. Matt also […]

In this episode, Scott Becker speaks with Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Matt shares insights into the current deal-making landscape, discussing how inflation, policy uncertainty, and market dynamics are shaping opportunities in private equity.

In this episode, Scott Becker speaks with Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Matt shares insights into the current deal-making landscape, discussing how inflation, policy uncertainty, and market dynamics are shaping opportunities in private equity.

In this episode, Matt Wolf, Health Care Senior Analyst and National Business Valuation Leader at RSM, discusses the impact of productivity trends on economic growth and the potential of generative AI to revolutionize healthcare. He explores how these technologies could free up clinical time and drive enterprise value in the coming years.

In this episode, Matt Wolf, Health Care Senior Analyst and National Business Valuation Leader at RSM, discusses the impact of productivity trends on economic growth and the potential of generative AI to revolutionize healthcare. He explores how these technologies could free up clinical time and drive enterprise value in the coming years.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his insights on the evolving IPO market, the return of take-private deals, and private equity’s growing interest in retail investors. Wolf also discusses how macroeconomic shifts are influencing capital reallocation and enterprise value creation.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, shares his insights on the evolving IPO market, the return of take-private deals, and private equity’s growing interest in retail investors. Wolf also discusses how macroeconomic shifts are influencing capital reallocation and enterprise value creation.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, discusses the current shifts in private equity, including a regime change from growth-focused strategies to sustainable growth. He explores how economic factors, such as potential Fed rate cuts and the impact of business continuity planning, are shaping […]

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, discusses the current shifts in private equity, including a regime change from growth-focused strategies to sustainable growth. He explores how economic factors, such as potential Fed rate cuts and the impact of business continuity planning, are shaping […]

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, discusses the impact of technology and AI on the consolidation of business professional services. He also shares insights on the current economic environment, interest rate expectations, and the outlook for private equity and middle market investments.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, discusses the impact of technology and AI on the consolidation of business professional services. He also shares insights on the current economic environment, interest rate expectations, and the outlook for private equity and middle market investments.

In this episode, frequent guest Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, provides an economic update and offers insights into the future economic landscape.

In this episode, frequent guest Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM, provides an economic update and offers insights into the future economic landscape.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM discusses current trends surrounding the private credit landscape.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM discusses current trends surrounding the private credit landscape.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares an update on the current deal environment.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares an update on the current deal environment.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares insights into current trends he is watching in commercial real estate.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares insights into current trends he is watching in commercial real estate.

In this episode, Scott has a conversation about GDP Day with Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM.

In this episode, Scott has a conversation about GDP Day with Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM.

Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM joins the podcast to discuss the democratization of investment into private markets.

Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM joins the podcast to discuss the democratization of investment into private markets.

Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM joins the podcast to share insights into the current macroeconomic data landscape and maybe why it isn't as important as it once was.

Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM joins the podcast to share insights into the current macroeconomic data landscape and maybe why it isn't as important as it once was.

In this episode, Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares data on private equity deal flow going into the end of Q1.

Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM joins the podcast to discuss the relationship between interest rates and private equity.

In this episode, regular guest Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares insight into the current healthcare & private equity regulatory landscape.

In this episode, regular guest Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares insights into what is going on in the private equity space today.

Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM joins the podcast to share an economic update.

In this episode, regular guest Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM shares a private equity deal flow update.

In this episode, regular guest Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM discusses return to office mandates and whether or not productivity is affected by remote or hybrid work.

This episode features Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Here, he discusses private equity deal flow trends he is keeping an eye on.

In this episode, regular guest Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM discusses the optimistic outlook surrounding deal flow in 2024.

This episode features Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Here, he shares an update on consumer spending, interest rates, and other economic trends that he is keeping an eye on.

This episode features Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM. Here, he discusses what he is seeing with private equity deal activity & what to expect for 2024.

Matt Wolf, Health Care Senior Analyst and National Health Care Business Valuation Leader at RSM rejoins the podcast to discuss the recent resurgence of the private equity deal market.